THBS1 and glioma: Furthermore, heme biosynthesis expression together with other newly established glioma biomarkers such as long non-coding RNA expression, thrombospondin-1 and circulating biomarker panels may in future assist to perform even more precise prognostic assessments of newly diagnosed gliomas (Tanase et al., 2015, 2022; Pop et al., 2018).